Lirilumab (anti-KIR)
规格
| Cas Number | 1000676-41-4 |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
| 级别 | 无动物源,无载体,重组,ExactAb™,低内毒素,无叠氮钠,已验证 |
| 纯度 | ≥95%(SDS-PAGE&SEC-HPLC) |
| 包装 | 10mg 或 1mg 或 5mg 或 100μg |
产品信息
| 别名 | CD158 antigen-like family member A antibody; CD158a antibody; KI2L1_HUMAN antibody; Killer cell immunoglobulin like receptor two domains long cytoplasmic tail 1 antibody; Killer cell immunoglobulin-like receptor 2DL1 antibody; KIR-K64 antibody; KIR221 antibody; KIR2DL1 antibody; MHC class I NK cell receptor antibody; Natural killer-associated transcript 1 antibody; NKAT antibody; NKAT 1 antibody; NKAT-1 antibody; p58 natural killer cell receptor clones CL-42/47.11 antibody; p58 NK receptor antibody; p58 NK receptor CL-42/47.11 antibody; p58.1 antibody; p58.1 MHC class-I-specific NK receptor antibody; CD158 antigen-like family member A; CD158; CD158a antigen; CD158Ankat1; cl-42; killer cell immunoglobulin-like receptor 2DL1; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1; killer Ig receptor; killer inhibitory receptor 2-2-1; KIR; KIR221; MHC class I NK cell receptor; Natural killer-associated transcript 1; NKAT; NKAT-1; NKAT1KIR-K64; p58 killer cell inhibitory receptor KIR-K64; p58 natural killer cell receptor clones CL-42/47.11; p58 NK cell inhibitory receptor NKR-K6,47.11; p58 NK receptor CL-42/47.11; p58.1 MHC class-I-specific NK receptor; p58.1; IPH2102; 利瑞鲁单抗 |
| 品牌 | 阿拉丁 |
| 浓度 | 见COA |
| Action Type | 抑制剂 |
| Mechanism Of Action | 杀伤细胞免疫球蛋白样受体 2DL1 抑制剂 |
| 简短描述 | Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated |
| 英文简短描述 | Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated |
| 稳定性和储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| 轻链类型 | kappa |
| 防腐剂（Preservatives） | No |
| 过滤标签 | Gene ID:3802,Accession#:P43626,KIR,KIR2DL1 |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| Clonality | 重组抗体 |
| 形式 | Whole IgG |
| Accession ID | P43626 |
| 物理形态 | 液体 |
| 特异性 | KIR2DL1 |
| Species reactivity（Reacts with) | 人(Human),小鼠(Mouse),食蟹猴(Cynomolgus monkey) |
| Conjugate | Unconjugated |
| 纯化方法 | Protein A purified |
| 储存缓冲液 | Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 亚型 | Human IgG4SP |
| Host species | 人(Human) |
| 靶标动物 | Human, Mouse, Cynomolgus monkey |
| 内毒素浓度 | <1.0 EU/mg |
| Source | CHO细胞培养上清 |
| 描述 |
Lirilumab (anti-KIR) 是一种 anti-KIR 单克隆抗体，其具有抗肿瘤活性。Lirilumab (anti-KIR) 可用于白血病、头颈部鳞状细胞癌 (SCCHN) 的研究。 |
| 英文描述 |
Lirilumab (anti-KIR) is an anti-KIR monoclonal antibody, and shows antitumor activity. Lirilumab (anti-KIR) can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research. |
| SDS-PAGE | 25.9 kDa (Light Chain) & 51.8 kDa (Heavy Chain), under reducing conditions; 175.5 kDa, under non-reducing conditions. |